RBM3 protein in testicular cancer diagnostics and prognostics

Details for Australian Patent Application No. 2010212769 (hide)

Owner Atlas Antibodies AB

Inventors Jirstrom, Karin; Eberhard, Jakob

Agent Pizzeys

Pub. Number AU-A-2010212769

PCT Pub. Number WO2010/092187

Priority PCT/ SE2009/000091 16.02.09 SE; 09167847.4 13.08.09 EP; PCT/ EP2009/067419 17.12.09 EP; 61/169,963 16.04.09 US; 09158084.5 16.04.09 EP; 61/233,769 13.08.09 US

Filing date 16 February 2010

Wipo publication date 19 August 2010

International Classifications

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

28 July 2011 PCT application entered the National Phase

  PCT publication WO2010/092187 Priority application(s): WO2010/092187

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010212772-Prediction of response to platinumbased therapy

2010212764-RBM3 protein in colorectal cancer prognostics